35 related articles for article (PubMed ID: 35347002)
1. Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
Toya R; Fukugawa Y; Saito T; Matsuyama T; Yoshida R; Murakami D; Orita Y; Nakayama H; Oya N
Oral Oncol; 2024 Apr; 151():106752. PubMed ID: 38518555
[TBL] [Abstract][Full Text] [Related]
2. Nutrition outcomes and treatment toxicities in patients with head and neck cancer receiving helical intensity-modulated radiotherapy.
Blake C; Lai R; Brown T; Pelecanos A; Moroney L; Helios J; Smith D; Hughes BGM; Kenny L; Chua B; Bauer J
J Hum Nutr Diet; 2024 Feb; 37(1):182-192. PubMed ID: 37737485
[TBL] [Abstract][Full Text] [Related]
3. Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.
Xiao C; Beitler JJ; Higgins KA; Conneely K; Dwivedi B; Felger J; Wommack EC; Shin DM; Saba NF; Ong LY; Kowalski J; Bruner DW; Miller AH
Brain Behav Immun; 2016 Feb; 52():145-152. PubMed ID: 26515035
[TBL] [Abstract][Full Text] [Related]
4. Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India.
Nath J; Sarma G; Paul M; Bhattacharyya M; Kalita AK; Medhi PP
Indian J Surg Oncol; 2023 Sep; 14(3):699-706. PubMed ID: 37900646
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Hypofractionated Palliative Radiotherapy Regimens for Patients With Advanced Head and Neck Cancer in Tikur Anbessa Hospital, Ethiopia: A Prospective Cohort Study.
Zingeta GT; Worku YT; Awol M; Woldetsadik ES; Assefa M; Chama TZ; Feyisa JD; Bedada HF; Adem MI; Mengesha T; Wong R
JCO Glob Oncol; 2024 Jan; 10():e2300253. PubMed ID: 38181315
[TBL] [Abstract][Full Text] [Related]
6. Dysphagia, hypothyroidism, and osteoradionecrosis after radiation therapy for head and neck cancer.
Ranta P; Kytö E; Nissi L; Kinnunen I; Vahlberg T; Minn H; Haapio E; Nelimarkka L; Irjala H
Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):108-116. PubMed ID: 35155788
[TBL] [Abstract][Full Text] [Related]
7. Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.
Lester SC; Moon DH; Patel SH; Awan MJ; Bakst RL
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):165-168. PubMed ID: 38049222
[No Abstract] [Full Text] [Related]
8. Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities.
Azzam P; Mroueh M; Francis M; Daher AA; Zeidan YH
Ecancermedicalscience; 2020; 14():1133. PubMed ID: 33281925
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy.
Eom KY
Radiat Oncol J; 2024 Mar; 42(1):1-3. PubMed ID: 38549379
[No Abstract] [Full Text] [Related]
10. Financial Counseling Is Associated with Reduced Financial Difficulty Scores in Head and Neck Cancer Patients Treated with Radiation Therapy.
Farrugia M; Yu H; Ma SJ; Iovoli AJ; Erickson K; Wendel E; Attwood K; Wooten KE; Gupta V; McSpadden RP; Kuriakose MA; Markiewicz MR; Chan JM; Hicks WL; Platek ME; Ray AD; Repasky EA; Singh AK
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34063890
[TBL] [Abstract][Full Text] [Related]
11. Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies.
Sahu RK; Ruhi S; Jeppu AK; Al-Goshae HA; Syed A; Nagdev S; Widyowati R; Ekasari W; Khan J; Bhattacharjee B; Goyal M; Bhattacharya S; Jangde RK
Front Oncol; 2023; 13():1204722. PubMed ID: 37469419
[TBL] [Abstract][Full Text] [Related]
12. Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model-A Narrative Review.
Mireștean CC; Iancu RI; Iancu DPT
Curr Oncol; 2023 May; 30(5):4805-4816. PubMed ID: 37232820
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and Modern Radiotherapy Technique for Older Patients with Locally Advanced Head and Neck Cancer: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
Nguyen NP; Kim L; Thariat J; Baumert BG; Mazibuko T; Gorobets O; Vinh-Hung V; Giap H; Mehmood T; Vincent F; Chi A; Basu T; Loganadane G; Mohammadianpanah M; Karlsson U; Oboite E; Oboite J; Ali A; Page BR
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358703
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Albumin and Neutrophil-to-Lymphocyte Ratio Score for Treatment Completeness and Safety Profiles in Patients With Head and Neck Cancer Receiving Definitive Concurrent Chemoradiotherapy.
Hsu CC; Chou WC; Hung YS; Lin SY; Hung CY; Yeh KY; Wang HM; Lu CH
In Vivo; 2022; 36(6):2875-2883. PubMed ID: 36309354
[TBL] [Abstract][Full Text] [Related]
15. Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.
Mayo ZS; Ilori EO; Matia B; Smile TD; Fleming CW; Reddy CA; Scharpf J; Lamarre ED; Prendes BL; Ku J; Burkey BB; Joshi NP; Woody NM; Koyfman SA; Campbell SR
Anticancer Res; 2022 Apr; 42(4):1845-1849. PubMed ID: 35347002
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
Toya R; Saito T; Yamaguchi K; Matsuyama T; Watakabe T; Matsumoto T; Yoshida R; Hirosue A; Murakami D; Orita Y; Nakayama H; Oya N
Radiat Oncol; 2020 May; 15(1):123. PubMed ID: 32460865
[TBL] [Abstract][Full Text] [Related]
17. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Beadle BM; Liao KP; Giordano SH; Garden AS; Hutcheson KA; Lai SY; Guadagnolo BA
Cancer; 2017 Jan; 123(2):283-293. PubMed ID: 27662641
[TBL] [Abstract][Full Text] [Related]
18. Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S; Sun R; Gherga E; Hammoud Y; Rouvier J; Mauvais O; Bockel S; Louvrier A; Lebbad A; Bontemps P; Ortholan C; Bourhis J; Lestrade L; Sun XS
Cancer Radiother; 2020 Dec; 24(8):812-819. PubMed ID: 33144061
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
